At the America's Health Insurance Plans Institute & Expo, a presentation focused on how artificial intelligence (AI) solutions can help payers deliver the seamless experience that consumers have come to expect.
At the America's Health Insurance Plans (AHIP) Institute & Expo, a presentation focused on how artificial intelligence (AI) solutions can help payers deliver the seamless experience that consumers have come to expect.
Bobbi Coluni, vice president of payer offering management at Truven HealthAnalytics, part of the IBM Watson Health, acknowledged that the traditional business model for insurers is under increasing pressure in a world of near-constant acquisitions and consolidation. Adding to this pressure is the fact that consumers have become accustomed to a smoother experience and now have higher expectations for convenience in every interaction. Together, these demands create an opportunity to “leverage data and cognitive services to reinvent the customer experience at every touchpoint,” she explained, which is one of the aims of IBM Watson.
To illustrate how consumers expect more information but are often disappointed when it comes to buying healthcare, Coluni recalled that she had recently had a surgery that was performed in an operating room instead of the outpatient setting she expected, and she was shocked when she received a bill of $19,000. If that situation could happen to someone who had spent years developing a cost transparency system, she pointed out, it can happen to other consumers who are making care decisions without having all the information they need.
Another barrier for insurance plan members is finding the answers for seemingly simple questions like which drugs are covered, how to submit a claim, or what coinsurance is. When they reach out to their insurer’s call center, the agents themselves struggle to find the right information, as it could reside in any one of a plethora of documents and locations. Thus, the system’s complexity creates a “perfect storm” of frustration for both the insurer’s members and employees.
That complexity is why IBM Watson thinks that its AI could be used to improve the member experience, answer questions consistently, and support health outcomes through every touchpoint. Coluni provided a sneak peek of the new Watson assistant for health benefits, which can be used for self-service chats. For instance, a member wondering if a knee replacement surgery is covered would “ask” Watson, which can eventually provide an estimate of the total out-of-pocket cost to the member. By accessing and weaving together all of that information, AI can ideally “inform that individual and answer the questions they didn’t ask but we know they need to understand,” she explained.
Coluni outlined several capabilities that payers should look for in an AI vendor:
While these might seem like a lot to ask of an AI system, Coluni agreed with fellow AHIP speaker Atul Gawande, MD, that it’s always possible to do better.
“At the time we’re living,” she concluded, “we have more technology and tools to change this member experience and change the way healthcare is delivered and will feel in the healthcare system than ever before.”
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Racial Variations in Cardiovascular Outcomes Found in Hidradenitis Suppurativa Study
March 19th 2024Based on the findings, investigators acknowledged the critical need to consider racial differences when assessing patients with hidradenitis suppurativa. Health care providers should be vigilant in addressing cardiovascular risk factors in this population, recognizing and addressing racial disparities that may impact disease management.
Read More